Zimmer Biomet and RevelAi Health signed a multiyear co-marketing agreement to commercialize artificial intelligence-powered care management platforms and other products.
Zimmer Biomet will commercialize RevelAi's artificial intelligence-powered care management platform, care team dashboard and future products. RevelAi's products help streamline care workflows while addressing healthcare disparities, Christian Péan, MD, CEO of RevelAi Health, said in a June 12 news release.
"Our AI-enabled asynchronous care model delivers personalized, timely, and effective patient care while reducing clinician burnout," he said. "Our collaboration with Zimmer Biomet is a significant step towards ensuring that every patient receives the care they deserve."